[
    {
        "utterance": "Tom Mansell: Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing more details about the plan.",
            "identify gap": "The speaker mentions being in 'very preliminary stages,' which implies a recognition of the current limitations or stage of their work.",
            "clarify goal": "The speaker mentions the plan and their current stage, which relates to defining or clarifying objectives or outcomes."
        }
    },
    {
        "utterance": "Tanya Nguyen: To follow up on what you're saying and also what Jay had mentioned earlier, and I have no idea how to do this, but it would be so cool to develop a way to kind of individually determine what someone's microbiome is at homeostasis, their ideal kind of microbiome environment, whether that be composition, metabolites, chemicals, and then use that as a baseline, and then being able to develop, you know, these different chemically engineered bacteria then produce specific metabolites to keep that person at that specific ideal level or attain an ideal level for them to then minimize their clinical symptoms or functioning. I think that would be a really cool idea, no idea how to get there, but happy to talk about it further and develop that. ",
        "annotations": {
            "propose new idea": "Tanya introduces a new idea of developing a method to determine someone's ideal microbiome environment and use chemically engineered bacteria.",
            "develop idea": "Tanya elaborates on her proposed idea, explaining how it could work.",
            "identify gap": "Tanya mentions she has 'no idea how to do this,' recognizing a gap in knowledge."
        }
    },
    {
        "utterance": "Tom Mansell: I think you could do it with one molecule. I don't know about all of those. But you know, if it's short chain fatty acids, I think that that's a great idea. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing a suggestion or a potential approach.",
            "offer feedback": "The speaker provides a suggestion for how to proceed with the idea.",
            "supportive response": "The speaker is expressing a positive evaluation for the idea."
        }
    },
    {
        "utterance": "Tom Mansell: Right now, I think, in general, the approaches, well, let's just make more, make more given prebiotics, given probiotics that we think are going to make butyrate. But you know, there might, there's probably a level that's too high, right? ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about producing prebiotics or probiotics to affect butyrate levels.",
            "offer feedback": "The speaker provides a cautionary note about potentially having too high levels of butyrate."
        }
    },
    {
        "utterance": "Tom Mansell: Do they take 12 different probiotic supplements every day to maintain that? You know, that's kind of the, yeah, so. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the practicality of taking multiple probiotic supplements daily."
        }
    },
    {
        "utterance": "Tom Mansell: Yeah, no, that's a good idea. I mean, there is this whole, you know, what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right? ",
        "annotations": {
            "develop idea": "The speaker is expanding on the previous idea by discussing the complexity of a healthy microbiome and metabolome, and how it varies by host factors.",
            "supportive response": "The speaker is expressing agreement and validation for the previous contribution."
        }
    },
    {
        "utterance": "Tom Mansell: You can blame it on behavior a little bit, but also there's probably genetic factors too, right, that influence your microbiome. I'm just gabbling, yeah. ",
        "annotations": {
            "develop idea": "Tom Mansell is expanding on previous ideas about factors influencing the microbiome, specifically mentioning behavior and genetic factors.",
            "express humor": "Tom Mansell makes a lighthearted comment about 'gabbling,' which can be considered an attempt to express humor."
        }
    },
    {
        "utterance": "Jae Sung: I guess we have many more questions than answers. That's because that's how science works. Very interesting. ",
        "annotations": {
            "summarize conversation": "Jae Sung is summarizing the current state of their discussion.",
            "supportive response": "Jae Sung is making a somewhat supportive comment about the current state of their research."
        }
    },
    {
        "utterance": "Tom Mansell: I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept, right? And so we talked, you know, Emily framed the discussion as, this is a bioreactor, right? This is, we have a whole core curriculum on this on reactor design. ",
        "annotations": {
            "signal expertise": "Tom Mansell explicitly states his background as a chemical engineer and mentions a core curriculum on reactor design.",
            "develop idea": "He elaborates on the concept of a bioreactor and reactor design.",
            "acknowledge contribution": "Tom Mansell acknowledges Emily's contribution to framing the discussion as a bioreactor concept."
        }
    },
    {
        "utterance": "Tom Mansell: A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right? And so, I love this idea of influencing motility as a way to manipulate the microbiome, and in doing so, manipulate the metabolome. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously mentioned concept (motility) and relating it to reactor design principles, showing an effort to build upon existing ideas through explanation and example.",
            "signal expertise": "The speaker is drawing on their knowledge of chemical engineering, specifically reactor design, to contribute to the discussion."
        }
    },
    {
        "utterance": "Faranak Fattahi: It's circular, and then it affects motility again. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously discussed idea about the relationship between certain factors and motility, suggesting a cyclical effect on motility."
        }
    },
    {
        "utterance": "Tom Mansell: Right. ",
        "annotations": {
            "Acknowledge contribution": "Tom Mansell is acknowledging a previous statement, showing that he is engaged and considered the points made.",
            "Supportive response": "The utterance 'Right.' serves as a supportive response, indicating agreement with the previous statement."
        }
    },
    {
        "utterance": "Tom Mansell: Yes, of course. And you know, like many processes, it probably is a small disruption that becomes non-linear, and then, you know, that's when you end up in a disease state. I don't know, I'm not that kind of doctor, but ",
        "annotations": {
            "Supportive response": "The speaker expresses agreement with a prior statement.",
            "Develop idea": "The speaker expands on an existing idea through reasoning.",
            "Identify gap": "The speaker identifies a gap in their expertise."
        }
    },
    {
        "utterance": "Tom Mansell: So, Faranak, I think we should talk about your ENS essay a little more. ",
        "annotations": {
            "encourage participation": "Tom Mansell is directly inviting Faranak to contribute to the discussion by suggesting they talk about Faranak's ENS essay."
        }
    },
    {
        "utterance": "Faranak Fattahi: Absolutely. Yeah, I'd love to. So we have actually done a lot of high throughput assays just looking at, you know, a library of neuroactive compounds. So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists. And many of them could be influenced by microbial products. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their own research experience and knowledge on the topic.",
            "develop idea": "The speaker is elaborating on their research and work done in the area."
        }
    },
    {
        "utterance": "Emily Balskus: Okay, so we we probably have five minutes or so left, maybe um uh yeah, so thinking about and it looks like Jay Jay might have stepped away from his computer. Thinking about you sort of condensing and highlighting the key takeaways, um yeah, maybe Sarah. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by mentioning the time constraint.",
            "summarize conversation": "The speaker is suggesting that the group should think about condensing and highlighting key takeaways."
        }
    },
    {
        "utterance": "Faranak Fattahi: I guess for me the the main takeaways are we have um so the field has identified many interesting correlations between um certain fermentation products and neurological disorders. Um and so we know that those actually are relevant to actual clinical data and in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological. ",
        "annotations": {
            "summarize conversation": "The utterance provides a summary of key points discussed, specifically about correlations between fermentation products and neurological disorders.",
            "develop idea": "The utterance expands slightly on existing ideas by providing more details about the relevance to clinical data and mouse models.",
            "identify gap": "The utterance implies a gap in knowledge by stating the need to expand understanding of other important products in overall neurological health."
        }
    },
    {
        "utterance": "Emily Balskus: Oh we really don't have yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance or it does not contain enough information to accurately apply another code."
        }
    },
    {
        "utterance": "Faranak Fattahi: And then we want to know if um we can build models to then get at the mechanistic steps where basically these um these products then you know, induce all these changes in the body that then translate into effects on the disease. Um I guess another important point was the medications and how they um get affected by the microbiome and then vice versa, how like management of these patients affects the motility and the composition of the microbes. So yeah, I guess Jay's back so. ",
        "annotations": {
            "Ask question": "The speaker requests information on building models to understand mechanistic steps.",
            "Develop idea": "The speaker is expanding on existing ideas by suggesting model development and discussing medication interactions with the microbiome.",
            "Summarize conversation": "The speaker is highlighting key points from the discussion."
        }
    },
    {
        "utterance": "Emily Balskus: Thanks Jay. ",
        "annotations": {
            "acknowledge contribution": "verbally recognizes another group member's input or presence"
        }
    },
    {
        "utterance": "Jae Sung: All right, I'm going to try to summarize all this to ",
        "annotations": {
            "summarize conversation": "The speaker explicitly states their intention to summarize the discussion that has taken place."
        }
    }
]